Correlation Between Fennec Pharmaceuticals and Harrow Health

Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Harrow Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Harrow Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fennec Pharmaceuticals and Harrow Health 8625, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Harrow Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Harrow Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Harrow Health.

Diversification Opportunities for Fennec Pharmaceuticals and Harrow Health

0.43

Correlation Coefficient

Fennec Pharmaceuticals  Harrow Health

Very weak diversification

The 3 months correlation between Fennec and Harrow is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Harrow Health 8625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health 8625 and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Harrow Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health 8625 has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Harrow Health go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and Harrow Health

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 9.76 times more return on investment than Harrow Health. However, Fennec Pharmaceuticals is 9.76 times more volatile than Harrow Health 8625. It trades about 0.04 of its potential returns per unit of risk. Harrow Health 8625 is currently generating about 0.15 per unit of risk. If you would invest  616.00  in Fennec Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  30.00  from holding Fennec Pharmaceuticals or generate 4.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Fennec Pharmaceuticals  vs.  Harrow Health 8625

Fennec Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Harrow Health 8625

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health 8625 are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Harrow Health is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Fennec Pharmaceuticals and Harrow Health

The main advantage of trading using opposite Fennec Pharmaceuticals and Harrow Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Harrow Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health will offset losses from the drop in Harrow Health's long position.

The idea behind Fennec Pharmaceuticals and Harrow Health 8625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.